Success Metrics

Clinical Success Rate
100.0%

Based on 27 completed trials

Completion Rate
100%(27/27)
Active Trials
1(4%)
Results Posted
11%(3 trials)

Phase Distribution

Ph phase_1
25
89%
Ph phase_2
2
7%
Ph phase_4
1
4%

Phase Distribution

25

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution28 total trials
Phase 1Safety & dosage
25(89.3%)
Phase 2Efficacy & side effects
2(7.1%)
Phase 4Post-market surveillance
1(3.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

27 of 27 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

28

all time

Status Distribution
Active(1)
Completed(27)

Detailed Status

Completed27
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 125 (89.3%)
Phase 22 (7.1%)
Phase 41 (3.6%)

Trials by Status

recruiting14%
completed2796%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07378579Phase 1

An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001

Completed
NCT06855264Phase 1

A Cardiac Liability Study of Varegacestat in Healthy Participants

Completed
NCT06649942Phase 1

A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults

Completed
NCT07162116Phase 1

A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants

Recruiting
NCT01944774Phase 2

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

Completed
NCT02050802Phase 1

Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

Completed
NCT04369391Phase 1

A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

Completed
NCT04819906Phase 1

Effect of Estetrol Monohydrate (E4) on QTc Interval

Completed
NCT01525394Phase 1

A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

Completed
NCT02820311Phase 1

Thorough QT (TQT) Study of TD-4208 in Healthy Subjects

Completed
NCT04867980Phase 1

A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants

Completed
NCT03489005Phase 1

Effect of BIA 5 1058 on Cardiac Repolarization

Completed
NCT03696459Phase 1

A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Participants

Completed
NCT02903836Phase 2

Phase II Study of Oral Nafithromycin in CABP

Completed
NCT01461460Phase 1

A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects

Completed
NCT02307864Phase 1

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Completed
NCT02293148Phase 1

Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

Completed
NCT01702376Phase 1

This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

Completed
NCT02436486Phase 1

Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

Completed
NCT02091310Phase 1

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Completed

Drug Details

Intervention Type
DRUG
Total Trials
28